Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus

Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus

Item
http://www.wikidata.org/entity/Q24548814
Regulation of glucose homeostasis by GLP-1Antitumoral activity of snake venom proteins: new trends in cancer therapyRgs16 and Rgs8 in embryonic endocrine pancreas and mouse models of diabetesMolecular Characterisation of Small Molecule Agonists Effect on the Human Glucagon Like Peptide-1 Receptor InternalisationPeptides, Peptidomimetics, and Polypeptides from Marine Sources: A Wealth of Natural Sources for Pharmaceutical Applications.Long term exendin-4 treatment reduces food intake and body weight and alters expression of brain homeostatic and reward markers.Oral Delivery of Pentameric Glucagon-Like Peptide-1 by Recombinant Lactobacillus in Diabetic Rats.Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells.IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test.Cross-Talk Between Insulin Signaling and G Protein-Coupled Receptors.Parabrachial Nucleus Contributions to Glucagon-Like Peptide-1 Receptor Agonist-Induced Hypophagia.Clinical experience with exenatide in obese North Indian patients with type 2 diabetes mellitus.Exenatide: a new promising antidiabetic agentA Modular Method for the High-Yield Synthesis of Site-Specific Protein-Polymer Therapeutics.Immunosuppressive evidence of Tityus serrulatus toxins Ts6 and Ts15: insights of a novel K(+) channel pattern in T cells.Exendin-4-encapsulated dissolving microneedle arrays for efficient treatment of type 2 diabetes.Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
P2860

Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus

Item
http://www.wikidata.org/entity/Q24548814
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus
@ast
Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus
@en
Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus
@nl
type
label
Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus
@ast
Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus
@en
Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus
@nl
prefLabel
Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus
@ast
Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus
@en
Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus
@nl
P1433
P1476
P2093
P2860
P304
P31
P3181
P407
P433
P478
P577
P698
P921
P932
P3181
P1433
P1476
Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus
@en
P2093
P2860
P304
P31
P3181
P407
P433
P478
P577
P698
P921
P932